Literature DB >> 2170237

Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis.

K Takeuchi1, S Boonmar, Y Kubo, T Katayama, H Harada, A Ohbayashi, Q L Choo, G Kuo, M Houghton, I Saito.   

Abstract

Using a specific hepatitis C virus (HCV) antibody assay, positive blood donors responsible for the transmission of post-transfusion non-A, non-B hepatitis (PT-NANBH) were identified. cDNA fragments were isolated from one of the plasma samples of such healthy HCV carriers by using polymerase chain reactions. Nucleotide (nt) sequence analyses of the cDNA from three different regions of the viral genome revealed that they were derived from a Japanese HCV isolate that was similar but not identical to the prototype HCV previously isolated from a chronically infected chimpanzee. Homology at the nt and amino acid levels was comparatively lower in the presumed structural region than in putative nonstructural regions. This result not only confirms that HCV antibody-positive blood contains infectious HCV, but suggests the existence of different type(s) of HCV.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170237     DOI: 10.1016/0378-1119(90)90102-w

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  24 in total

Review 1.  Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations.

Authors:  A Della Rossa; G Trevisani; S Bombardieri
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Intrafamilial transmission of hepatitis C virus in Japan.

Authors:  K Michitaka; M Onji; N Horiike; K Kajino; I Saito; T Miyamura; Y Ohta
Journal:  Gastroenterol Jpn       Date:  1991-10

3.  Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma.

Authors:  T A Cha; J Kolberg; B Irvine; M Stempien; E Beall; M Yano; Q L Choo; M Houghton; G Kuo; J H Han
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

4.  A second group of hepatitis C viruses.

Authors:  K Tsukiyama-Kohara; M Kohara; K Yamaguchi; N Maki; A Toyoshima; K Miki; S Tanaka; N Hattori; A Nomoto
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

5.  Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome.

Authors:  W H Chou; T Yoneyama; K Takeuchi; H Harada; I Saito; T Miyamura
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

6.  Reduction of synonymous substitutions in the core protein gene of hepatitis C virus.

Authors:  Y Ina; M Mizokami; K Ohba; T Gojobori
Journal:  J Mol Evol       Date:  1994-01       Impact factor: 2.395

7.  Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand.

Authors:  P Sawanpanyalert; S Boonmar; T Maeda; Y Matsuura; T Miyamura
Journal:  J Epidemiol Community Health       Date:  1996-04       Impact factor: 3.710

8.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

Authors:  N Ogata; H J Alter; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus.

Authors:  J Chiba; H Ohba; Y Matsuura; Y Watanabe; T Katayama; S Kikuchi; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.